Clinical trials
Hemorrhagic Stroke, Intracerebral clinical trials
Below are recruiting hemorrhagic stroke, intracerebral clinical trials, each written for real people, not researchers. We’re tracking 60 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07187687Recruiting
Early minimally invasive clot removal for brain hemorrhage
This study tests if removing a large brain clot early using a small tube and clot-dissolving medicine can improve recovery after a hemorrhagic stroke. It is for people with a moderate to large bleed who can start treatment within 12 hours of symptoms.
Guangdong, YuexiuAges 18 years+ - NCT06402968Recruiting
Clevidipine for treating high blood pressure after a brain bleed
This trial tests a blood pressure medicine called clevidipine given through an IV to people with a brain bleed (intracerebral hemorrhage). The goal is to see if quickly lowering blood pressure helps prevent more bleeding and improve recovery.
Irvine, CaliforniaAges 18–100 - NCT04707105Recruiting
Study of brain bleeding in hospitalized adults
This study follows adults who are hospitalized after a type of brain bleed called primary intracerebral hemorrhage. It mainly tracks what happens after the bleeding to help doctors understand outcomes and care needs.
Hangzhou, ZhejiangAges 18 years+ - NCT04916210Recruiting
Study how stroke type affects thinking and recovery
This study looks at what predicts memory and thinking problems after different types of stroke or brain bleeding, and how blood-vessel changes relate to recovery. You may be invited if you recently had a stroke/bleed and can complete a baseline check within 6 weeks.
Phoenix, ArizonaAges 18 years+ - NCT05378490Recruiting
Study of stroke types and thrombolysis treatment
This study includes people who have had certain kinds of sudden brain blood-flow problems (like an ischemic stroke, bleeding in the brain, or a brief warning episode) or conditions that look similar. It looks at how treatment such as clot-busting medicine (thrombolysis) fits for these situations.
LørenskogAges 18 years+ - NCT05836831RecruitingPhase 4
Tranexamic acid for sudden brain bleeding after stroke
This trial studies whether tranexamic acid (a medicine that helps blood clot) can improve outcomes after a spontaneous (not caused by injury) brain bleed. It is designed for adults who arrive soon after stroke symptoms start and meet several safety and timing requirements.
Guntur, Andhra PradeshAges 18–99 - NCT05891509Recruiting
DTI-guided minimally invasive surgery for deep brain bleeding
This trial studies whether a special scan-guided, minimally invasive procedure can safely remove bleeding in the basal ganglia (deep in the brain) soon after it happens. It may help patients recover better by targeting the bleeding while protecting important brain pathways.
Ganzhou, JiangxiAges 18–80 - NCT06429332RecruitingPhase 4
Care bundle study for brain bleed on CT scan
This trial is testing a set of standard care steps (a 'care bundle') for people who have a sudden brain bleed (intracerebral hemorrhage) that shows up on a CT scan. It aims to see if this bundle improves recovery and outcomes.
Oklahoma City, OklahomaAges 18 years+ - NCT06548737Recruiting
Outcomes after a brain bleed
This study looks at what happens to people after a bleed in the brain. It will help doctors understand how people recover, so they can improve care for future patients.
Hangzhou, ZhejiangAges 18–100 - NCT06670456Recruiting
Brain Bleed Study (Without Surgery)
This study is for people who had a spontaneous brain bleed and did not have surgery. It aims to learn more about their recovery and health over time.
Fuzhou, FujianAges 18 years+ - NCT06728592Recruiting
Emergency stroke unit for ischemic stroke within 6 hours
This trial tests a dedicated emergency stroke unit for people with ischemic stroke who can get treatment within 6 hours of symptoms starting. It aims to see if this special care area improves outcomes.
Hong KongAges 18–100 - NCT06763055RecruitingPhase 3
Study of two drugs for spontaneous brain bleed recovery
This trial compares two medicines (deferoxamine and colchicine) to see if they can prevent further brain damage after a spontaneous brain bleed (intracerebral hemorrhage). The goal is to improve recovery by reducing inflammation and iron-related damage.
Sydney, New South WalesAges 18–80 - NCT07052045Recruiting
One-stop emergency care for fast stroke treatment
This trial tests a streamlined approach to quickly start endovascular therapy for people having a severe ischemic stroke caused by a blocked large or medium brain artery. It aims to reduce delays and improve recovery by coordinating the care team as soon as you arrive at the hospital.
NurembergAges 18 years+ - NCT07053917RecruitingPhase 1
Psilocybin therapy for stroke recovery
This trial tests whether a medicine called psilocybin (a psychedelic compound) can help people who had a stroke more than a year ago. It aims to see if the therapy can improve healing and flexibility in the brain.
Baltimore, MarylandAges 18 years+ - NCT07088250Recruiting
Statins for Treating Brain Bleeding
This trial tests if the statin drug atorvastatin can help people recover from a type of stroke called a brain bleed. It is for adults who have a moderate-sized bleed in the upper part of the brain and can start taking the drug within 48 hours of symptoms.
Anqing, AnhuiAges 18–80 - NCT07166146Recruiting
Recovery timing after brain bleed surgery
This trial looks at how people recover after surgery for a brain bleed (intracerebral hemorrhage). It aims to find the best timing for treatment to improve recovery. If you have had a brain bleed and are eligible for surgery, you may be able to join.
BeijingAges 18–80 - NCT07227246RecruitingPhase 3
Testing rFVIIa for bleeding stroke within 2 hours
This trial tests whether a drug called Recombinant Factor VIIa (rFVIIa) can safely help stop bleeding in the brain during a hemorrhagic stroke. The goal is to give the drug as quickly as possible, within 2 hours of stroke onset, to see if it improves outcomes.
Birmingham, AlabamaAges 18–80 - NCT07234955Recruiting
Minimally invasive surgery for deep brain bleeding
This trial tests a minimally invasive surgery to remove blood clots deep in the brain after a spontaneous bleed. It may help patients with moderate to large bleeds who are at least 18 and up to 80 years old.
Ho Chi Minh City, Ho Chi MinhAges 18–80 - NCT07237048RecruitingPhase 2/Phase 3
Minocycline for stroke recovery
This trial tests if the antibiotic minocycline can help people recovering from a stroke. It is for adults who have had a stroke within the last 24 hours and have moderate symptoms based on a standard stroke scale.
Brooklyn, New YorkAges 18 years+ - NCT07246473Recruiting
Non-invasive ultrasound for brain bleed clearance
This trial tests a non-invasive ultrasound device to help clear blood clots from the brain after a spontaneous bleed. It may be an option for people with small to medium-sized bleeds who do not need surgery.
Wuhu, AnhuiAges 18–80 - NCT07319013Recruiting
AI Ultrasound for Early Brain Bleed Detection
This trial uses an AI-assisted ultrasound to quickly detect brain bleeding in people with acute stroke. It may help speed up diagnosis and treatment.
Barcelona, CataloniaAges 18 years+ - NCT07338175RecruitingPhase 3
Testing minocycline for brain bleeding recovery
This trial tests if the antibiotic minocycline can help people recover after a spontaneous brain bleed (intracerebral hemorrhage). It is for patients who have a moderate-sized bleed and are within 48 hours of symptoms starting.
Beijing, Beijing MunicipalityAges 18–80 - NCT07365150Recruiting
Tranexamic acid for brain bleeding
This study tests whether the drug tranexamic acid can help stop bleeding in the brain when given early. It is for people with a spontaneous brain bleed who are awake and can be treated within 6 hours.
Hong KongAges 18 years+ - NCT07410624Recruiting
Kidney function in brain injury patients
This trial measures how quickly the kidneys clear drugs in patients with serious brain conditions like stroke or meningitis. It may help doctors adjust medicine doses for better treatment.
Lexington, KentuckyAges 18–85
Hear when a new Hemorrhagic Stroke, Intracerebral trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hemorrhagic stroke, intracerebral?
- Yes. Clin2 currently lists 60 recruiting hemorrhagic stroke, intracerebral studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hemorrhagic stroke, intracerebral trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hemorrhagic stroke, intracerebral trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.